4//SEC Filing
Garg Vipin K 4
Accession 0001104659-24-010778
CIK 0001326190other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:00 PM ET
Size
14.7 KB
Accession
0001104659-24-010778
Insider Transaction Report
Form 4
Garg Vipin K
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001
2024-02-01+16,545→ 288,767 total - Tax Payment
Common Stock, par value $0.0001
2024-02-01$9.88/sh−7,313$72,252→ 281,454 total - Exercise/Conversion
Common Stock, par value $0.0001
2024-02-02+18,950→ 300,404 total - Tax Payment
Common Stock, par value $0.0001
2024-02-02$9.32/sh−8,376$78,064→ 292,028 total - Exercise/Conversion
Restricted Stock Units
2024-02-02−18,950→ 37,900 total→ Common Stock, par value $0.0001 (18,950 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-01−16,545→ 16,545 total→ Common Stock, par value $0.0001 (16,545 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F2]Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
- [F3]The RSUs become vested in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date
- [F4]The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001515813
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 6:00 PM ET
- Size
- 14.7 KB